Visit the ACCC COVID-19 Resource Center & Discussion Group for Insights on Providing Optimal Patient Care During the Pandemic.


Oral oncolytics offer a host of benefits for both patients and providers, but cancer programs need to be equipped to properly manage and monitor patients who are self-administering their treatments at home.

About This Project

Oral Oncolytics PublicationWHITE PAPER

Read the white paper, Steps to Success: Implementing Oral Oncolytics from ACCC Member Programs, for effective practices, peer-to-peer insight, tools, and resources.

Our Sponsor

Pfizer Oncology

Sponsored by Pfizer Oncology.